Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Abnormal patterns of HPA axis activation, under basal conditions and in response to stress, are found in individuals with schizophrenia and bipolar disorder. Altered glucocorticoid receptor (GR) mRNA and protein expression in the dorsolateral prefrontal cortex (DLPFC) in psychiatric illness have also been reported, but the cause of these abnormalities is not known. We quantified expression of GR mRNA transcript variants which employ different 5' promoters, in 35 schizophrenia cases, 31 bipolar disorder cases and 34 controls. We also explored whether sequence variation within the NR3C1 (GR) gene is related to GR mRNA variant expression. Total GR mRNA was decreased in the DLPFC in schizophrenia cases relative to controls (15.1%, p<0.0005) and also relative to bipolar disorder cases (8.9%, p<0.05). GR-1B mRNA was decreased in schizophrenia cases relative to controls (20.2%, p<0.05), while GR-1C mRNA was decreased in both schizophrenia and bipolar disorder cases relative to controls (16.1% and 17.2% respectively, both p<0.005). A dose-dependent effect of rs10052957 genotype on GR-1B mRNA expression was observed, where CC homozygotes displayed 18.4% lower expression than TC heterozygotes (p<0.05), and 31.8% lower expression than TT homozygotes (p<0.005). Similarly, a relationship between rs6190 (R23K) genotype and GR-1C expression was seen, with 24.8% lower expression in GG homozygotes than GA heterozygotes (p<0.01). We also observed an effect of rs41423247 (Bcl1) SNP on expression of 67 kDa GRα isoform, the most abundant GRα isoform in the DLPFC. These findings suggest possible roles for the GR-1B and GR-1C promoter regions in mediating GR gene expression changes in psychotic illness, and highlight the potential importance of sequence variation within the NR3C1 gene in modulating GR mRNA expression in the DLPFC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A post-mortem study of patients with a schizophrenia diagnosis found a significant decrease in GR mRNA expression in the dorsolateral prefrontal cortex [79,80] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 1×
“edu/purcell / plink) [49] was used for Hardy-Weinberg equilibrium testing.”
MethodStress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · cited 1×
“adaptation [1].”
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Obstetric Complications and Schizophrenia: Historical and Meta-Analytic Review
Cannon, M., Jones, P. B., & Murray, R. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1080 · Cited by 1,137 · cited 1×
“Some early life experiences, such as obstetric complications, are risk factors for schizophrenia but possibly not for bipolar disorder [43,44].”
BackgroundBinder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968 · cited 1×
“Other stress signalling genes such as FKBP5 have also been implicated in bipolar disorder [15,16].”
BackgroundSelemon, L. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950220015005 · Cited by 876 · cited 1×
“A number of neuropathological changes, such as increased DLPFC neuron density, are observed in schizophrenia but have not been detected in bipolar disorder [45,46].”
BackgroundCannon, M., Caspi, A., Moffitt, T. E., Harrington, H., Taylor, A., Murray, R. M., & Poulton, R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.449 · Cited by 783 · cited 1×
“Some early life experiences, such as obstetric complications, are risk factors for schizophrenia but possibly not for bipolar disorder [43,44].”
BackgroundRajkowska, G., Halaris, A., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 570 · cited 1×
“A number of neuropathological changes, such as increased DLPFC neuron density, are observed in schizophrenia but have not been detected in bipolar disorder [45,46].”
BackgroundAgid, O., Shapira, B., Zislin, J., Ritsner, M., Hanin, B., Murad, H., Troudart, T., Bloch, M., Heresco-Levy, U., & Lerer, B. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000473 · Cited by 568 · cited 1×
“Some early life experiences, such as early parental loss and childhood abuse, are common risk factors for both schizophrenia and bipolar disorder [30].”
BackgroundReduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001308 · Cited by 532 · cited 1×
“At the molecular level, numerous mRNA transcripts and proteins are altered in both schizophrenia and bipolar disorder, including brain-derived neurotrophic factor (BDNF), glutamic acid decarboxylase-67 (GAD-67) and growth-associated protein-43 (GAP-43) [32–38].”
BackgroundCortical Thickness and Subcortical Volumes in Schizophrenia and Bipolar Disorder
Rimol, L. M., Hartberg, C. B., Nesvåg, R., Fennema-Notestine, C., Hagler, D. J., Pung, C. J., Jennings, R. G., Haukvik, U. K., Lange, E., Nakstad, P. H., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.036 · Cited by 454 · cited 1×
“Psychotic features are common to both bipolar I disorder and schizophrenia, as are some neuropathological changes such as reduced hippocampal volume [29].”
BackgroundWebster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420 · cited 5×
“Decreased expression of total GR mRNA is evident in the dorsolateral prefrontal cortex (DLPFC) in schizophrenia [2,3], in the temporal cortex, hippocampus and amygdala in schizophrenia”
BackgroundMethodSelf-citationDownregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone
Schaaf, M. J. M., de Jong, J., de Kloet, E. R., & Vreugdenhil, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01010-5 · Cited by 360 · cited 1×
“Some of these transcripts, such as BDNF and GAP-43, are down-regulated by cortisol [39–41].”
BackgroundRay, M. T., Weickert, C. S., Wyatt, E., & Webster, M. J. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100048 · Cited by 354
Self-citationWüst, S., van Rossum, E. F. C., Federenko, I. S., Koper, J. W., Kumsta, R., & Hellhammer, D. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031148 · Cited by 348 · cited 1×
“GG homozygotes have also been reported to have lower cortisol responses to psychosocial stress, and be at increased risk of major depression [7,13].”
BackgroundHypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
Watson, S., Gallagher, P., Ritchie, J. C., Ferrier, I. N., & Young, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.496 · Cited by 343 · cited 2×
“These abnormalities of GR expression occur in the context of broader HPA axis dysregulation, which is observed in many individuals with schizophrenia and bipolar disorder and is characterised by increased cortisol secretion and diminished dexamethasone suppression in the illnesses [5,6].”
BackgroundPolymorphisms of the Glucocorticoid Receptor Gene and Major Depression
van Rossum, E. F. C., Binder, E. B., Majer, M., Koper, J. W., Ising, M., Modell, S., Salyakina, D., Lamberts, S. W. J., & Holsboer, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.007 · Cited by 324
Eastwood, S. L., & Harrison, P. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00530-5 · Cited by 263 · cited 1×
“At the molecular level, numerous mRNA transcripts and proteins are altered in both schizophrenia and bipolar disorder, including brain-derived neurotrophic factor (BDNF), glutamic acid decarboxylase-67 (GAD-67) and growth-associated protein-43 (GAP-43) [32–38].”
BackgroundBradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 256
Turner, J. D., & Muller, C. P. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01822 · Cited by 256
Koper, J. W., Stolk, R. P., de Lange, P., Huizenga, N. A. T. M., Molijn, G.-J., Pols, H. A. P., Grobbee, D. E., Karl, M., de Jong, F. H., Brinkmann, A. O., et al. (1997) · Human Genetics · doi:10.1007/s004390050425 · Cited by 235 · cited 1×
“The rs6190 SNP is a non-synonymous coding SNP located in codon 23 of exon 2, which results in the substitution of an arginine (R) residue for a lysine (K) in the translated receptor amino acid sequence [24].”
BackgroundDatson, N. A., Van Der Perk, J., De Kloet, E. R., & Vreugdenhil, E. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01685.x · Cited by 230 · cited 1×
“Some of these transcripts, such as BDNF and GAP-43, are down-regulated by cortisol [39–41].”
BackgroundKumsta, R., Entringer, S., Koper, J. W., van Rossum, E. F. C., Hellhammer, D. H., & Wüst, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.013 · Cited by 187 · cited 1×
“GR gene polymorphisms have been shown to impact HPA axis stress responsiveness [7–10], and may contribute to an individual’s vulnerability to maladaptive stress responses and to their propensity to develop psychiatric illness [11].”
BackgroundThompson, M., Weickert, C. S., Wyatt, E., & Webster, M. J. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.02.005 · Cited by 185 · cited 1×
“At the molecular level, numerous mRNA transcripts and proteins are altered in both schizophrenia and bipolar disorder, including brain-derived neurotrophic factor (BDNF), glutamic acid decarboxylase-67 (GAD-67) and growth-associated protein-43 (GAP-43) [32–38].”
BackgroundSelf-citationCorticosteroid receptor polymorphisms: Determinants of vulnerability and resilience
DeRijk, R. H., & de Kloet, E. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.072 · Cited by 184 · cited 1×
“GR gene polymorphisms have been shown to impact HPA axis stress responsiveness [7–10], and may contribute to an individual’s vulnerability to maladaptive stress responses and to their propensity to develop psychiatric illness [11].”
BackgroundGlucocorticoid Sensitivity Is Determined by a Specific Glucocorticoid Receptor Haplotype
Stevens, A., Ray, D. W., Zeggini, E., John, S., Richards, H. L., Griffiths, C. E. M., & Donn, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031235 · Cited by 177 · cited 1×
“In addition, as part of a haplotype with rs33388 and rs33389 in intron B, healthy G carriers display lower post-dexamethasone cortisol levels [26].”
BackgroundGlucocorticoid Receptor Gene-Based SNP Analysis in Patients with Recurrent Major Depression
West, D. V., Eede, F. V. D., Del‐Favero, J., Souery, D., Norrback, K., van Duijn, C. M., Sluijs, S., Adolfsson, R., Mendlewicz, J., Deboutte, D., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300898 · Cited by 171 · cited 2×
“This hypothesis is supported by evidence of association of genetic polymorphisms in the GR gene with risk for bipolar disorder [12] and major depression [13,14].”
MethodResultPerlman, W. R., Webster, M. J., Kleinman, J. E., & Weickert, C. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.006 · Cited by 163 · cited 1×
“and bipolar disorder [2,4], and in the entorhinal cortex in bipolar disorder [2].”
BackgroundSelf-citationMultiple Promoters Exist in the Human GR Gene, One of Which Is Activated by Glucocorticoids
Breslin, M. B. (2001) · Molecular Endocrinology · doi:10.1210/me.15.8.1381 · Cited by 161 · cited 1×
“mRNA variants identified to date [17–21] (Figure 1).”
BackgroundFamily-based association of FKBP5 in bipolar disorder
Willour, V. L., Chen, H., Toolan, J., Belmonte, P., Cutler, D. J., Goes, F. S., Zandi, P. P., Lee, R. S., MacKinnon, D. F., Mondimore, F. M., et al. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002141 · Cited by 158
Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder
GALLAGHER, P., WATSON, S., SMITH, M., YOUNG, A., & FERRIER, I. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.020 · Cited by 129
Hansson, A. C., Cintra, A., Belluardo, N., Sommer, W., Bhatnagar, M., Bader, M., Ganten, D., & Fuxe, K. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00185.x · Cited by 124 · cited 1×
“Some of these transcripts, such as BDNF and GAP-43, are down-regulated by cortisol [39–41].”
BackgroundBrouwer, J. P., Appelhof, B. C., van Rossum, E. F. C., Koper, J. W., Fliers, E., Huyser, J., Schene, A. H., Tijssen, J. G. P., van Dyck, R., Lamberts, S. W. J., et al. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.08.001 · Cited by 124
Rosmond, R., Chagnon, Y. C., Chagnon, M., Përusse, L., Bouchard, C., & Björntorp, P. A. (2000) · Metabolism · doi:10.1053/meta.2000.7712 · Cited by 121
Selection of Reference Gene Expression in a Schizophrenia Brain Cohort
Weickert, C. S., Sheedy, D., Rothmond, D. A., Dedova, I., Fung, S., Garrick, T., Wong, J., Harding, A. J., Sivagnanansundaram, S., Hunt, C., et al. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903393662 · Cited by 106 · cited 1×
“conducted as previously reported [48].”
Zong, J., Ashraf, J., & Thompson, E. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5580 · Cited by 103
Presul, E., Schmidt, S., Kofler, R., & Helmberg, A. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02183 · Cited by 93 · cited 2×
“mRNA variants identified to date [17–21] (Figure 1).”
BackgroundFöcking, M., Dicker, P., English, J. A., Schubert, K. O., Dunn, M. J., & Cotter, D. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.43 · Cited by 90 · cited 1×
“At the molecular level, numerous mRNA transcripts and proteins are altered in both schizophrenia and bipolar disorder, including brain-derived neurotrophic factor (BDNF), glutamic acid decarboxylase-67 (GAD-67) and growth-associated protein-43 (GAP-43) [32–38].”
BackgroundSinclair, D., Tsai, S.-Y., Woon, H. G., & Weickert, C. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.160 · Cited by 70 · cited 8×
“Decreased expression of total GR mRNA is evident in the dorsolateral prefrontal cortex (DLPFC) in schizophrenia [2,3], in the temporal cortex, hippocampus and amygdala in schizophrenia”
BackgroundMethodResultSelf-citationReduced GAP-43 mRNA in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
Weickert, C. S. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.2.136 · Cited by 65 · cited 1×
“At the molecular level, numerous mRNA transcripts and proteins are altered in both schizophrenia and bipolar disorder, including brain-derived neurotrophic factor (BDNF), glutamic acid decarboxylase-67 (GAD-67) and growth-associated protein-43 (GAP-43) [32–38].”
BackgroundVan Rossum, E. F. C., Roks, P. H. M., De Jong, F. H., Brinkmann, A. O., Pols, H. A. P., Koper, J. W., & Lamberts, S. W. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02132.x · Cited by 59
Carvalho, L. A., Garner, B. A., Dew, T., Fazakerley, H., & Pariante, C. M. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.006 · Cited by 56 · cited 1×
“Furthermore, although in vitro work has characterised the effects of antidepressants on GR transcription and function [27,28], such effects of antipsychotics on GR have not been established [27].”
BackgroundIn vitro modulation of the glucocorticoid receptor by antidepressants
Carvalho, L. A., & Pariante, C. M. (2008) · Stress · doi:10.1080/10253890701850759 · Cited by 56 · cited 1×
“Furthermore, although in vitro work has characterised the effects of antidepressants on GR transcription and function [27,28], such effects of antipsychotics on GR have not been established [27].”
BackgroundCharacterization of promoter 1B in the human glucocorticoid receptor gene
Nunez, B. S., & Vedeckis, W. V. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00676-1 · Cited by 56 · cited 1×
“mRNA variants identified to date [17–21] (Figure 1).”
BackgroundTian, S. Y., Wang, J., Bezchlibnyk, Y. B., & Young, L. T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.031 · Cited by 45
West, D. V., Del‐Favero, J., Deboutte, D., Broeckhoven, C. V., & Claes, S. J. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.04.002 · Cited by 38 · cited 1×
“GR gene polymorphisms have been shown to impact HPA axis stress responsiveness [7–10], and may contribute to an individual’s vulnerability to maladaptive stress responses and to their propensity to develop psychiatric illness [11].”
BackgroundSpijker, A. T., Van Rossum, E. F. C., Hoencamp, E., DeRijk, R. H., Haffmans, J., Blom, M., Manenschijn, L., Koper, J. W., Lamberts, S. W., & Zitman, F. G. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00647.x · Cited by 36
Spijker, A. T., Giltay, E. J., van Rossum, E. F. C., Manenschijn, L., DeRijk, R. H., Haffmans, J., Zitman, F. G., & Hoencamp, E. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.020 · Cited by 30 · cited 2×
“In bipolar disorder patients, the rs6190 SNP may impact illness course, with carriers of the rs6190 SNP displaying an 8 year earlier onset of their first hypomanic episode than non-carriers [23].”
Background
Research works printed but not linked: 1
- Weickert CS Sheedy D Rothmond DA Dedova I Fung S 2010 Selection of reference gene expression in a schizophrenia brain cohort. Australian and New Zealand Journal of Psychiatry 44 59 70 20073568 PMC2950262 · DOI · Paper page
Cited by
Lucassen, P. J., Pruessner, J., Sousa, N., Almeida, O. F. X., Van Dam, A. M., Rajkowska, G., Swaab, D. F., & Czéh, B. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1223-5 · Cited by 441
“Furthermore, abnormal GR isoform expression levels have been found in the PFC of patients with psychiatric disorders like schizophrenia, bipolar and major depressive disorders [162, 190, 192].”
The HPA axis in bipolar disorder: Systematic review and meta-analysis
Belvederi Murri, M., Prestia, D., Mondelli, V., Pariante, C., Patti, S., Olivieri, B., Arzani, C., Masotti, M., Respino, M., Antonioli, M., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.014 · Cited by 391
The traumagenic neurodevelopmental model of psychosis revisited
Read, J., Fosse, R., Moskowitz, A., & Perry, B. (2014) · Neuropsychiatry · doi:10.2217/npy.13.89 · Cited by 262
Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis
Girshkin, L., Matheson, S. L., Shepherd, A. M., & Green, M. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.013 · Cited by 215
Biomarkers in Schizophrenia: A Brief Conceptual Consideration
Weickert, C. S., Weickert, T. W., Pillai, A., & Buckley, P. F. (2013) · Disease Markers · doi:10.1155/2013/510402 · Cited by 176
“Further, development of longitudinal assessment of schizophrenia over time with a goal of developing biomarkers will take thoughtful leadership, large multidisciplinary teams, well-organized research protocols, and grand-scale funding from government, corporate, and private sources.”
Background
Metadata
- Authors
- Sinclair, D., Fullerton, J. M., Webster, M. J., & Shannon Weickert, C.
- Affiliations
- UNSW Sydney (AU)
- Uniformed Services University of the Health Sciences (US)
- Corresponding author
- Sinclair, Duncan
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-13
- Volume
- 7
- Issue
- 3
- Pages
- e31720
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3302776
- OpenAlex
- W2044279458
- Cited by
- 71
- References
- 48
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 8 · 2019: 2 · 2018: 2 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 7 · 2013: 10 · 2012: 2
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Stanley Medical Research Institute
- Neuroscience Research Australia
- University of New South Wales
- Macquarie Group Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- glucocorticoid receptor, NR3C1, schizophrenia, bipolar disorder, dorsolateral prefrontal cortex, hypothalamic-pituitary-adrenal axis, gene expression regulation
- MeSH terms
- Adult, Analysis of Variance, Bipolar Disorder, Female, Gene Expression Regulation, Genotype, Homozygote, Humans, Male, Middle Aged, Polymorphism, Genetic, Promoter Regions, Genetic, Receptors, Glucocorticoid, RNA, Messenger, Schizophrenia, Suicide, Prefrontal Cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.